|
|
|
Available: 0 |
List Price:$279.99 |
|
Other formats:
|
Edition: | 1st |
Publisher: | Springer Nature |
ISBN: | 1-4419-9754-7 (1441997547) |
ISBN-13: | 978-1-4419-9754-8 (9781441997548) |
Binding: | Hardcover |
Copyright: | 2013 |
Publish Date: | 12/12 |
Weight: | 1.68 Lbs. |
Pages: | 447 |
Subject Class: | ONC (Oncology) |
Remarks: | Print on demand. If not in stock, allow additional time for processing |
Return Policy: | Returns accepted up to 12 months provided no other recalls or return restrictions apply. |
Table Of Contents: |
View
|
Contributing Authors: |
View
|
ProQuest Ebook Central: |
Available in ProQuest Ebook Centralâ„¢ View
|
|
|
|
Discipline: | Pathology | Subject Definition: | Neoplasms-Diagnosis; Biological Markers | NLM Class: | QZ 241 | LC Class: | RC270.3 | Abstract: | This integrated book covers the entire spectrum of cancer biomarkers in development and clinical use. Predictive and prognostic markers are explored in the context of colon cancer, breast cancer, lung cancer, prostate cancer, and GIST. International experts provide insight into toxicity markers and surrogate markers. Attention is also given to biomarker assay development, validation, and strategies. A powerful tool for determining decisions on therapy, selecting drug regimens, monitoring the efficacy of treatment, and performing individualized surveillance, biomarkers represent the forefront of cancer research and treatment. As these technologies become increasingly available for clinical use, this book will be an essential resource for oncologists and translational researchers. |
|
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews